Press Release Nicox: 2024 Ordinary and Extraordinary Shareholder MeetingApril 9, 2024 release at 17:30 CET Sophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124, ALCOX), an international...
Nicox SA Soci©t© anonyme with a registered capital of ‚ 50,299,694 Head Office: Sundesk Sophia Antipolis, Emerald Square, rue Evariste Galois “ 06410 BiotR.C.S. ANTIBES 403.942.642 On April 2nd,...
Press Release Results from Mont Blanc Phase 3 Trial of Nicox's NCX 470 in Glaucoma Published in the American Journal of Ophthalmology First publication of the data from the Mont Blanc Phase 3...
Nicox SA Société anonyme with a registered capital of ‚¬ 50,186,094 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis¯ R.C.S. GRASSE 403.942.642 On February 1st,...
Nicox SA Société anonyme with a registered capital of ‚¬ 50,170,498 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis¯ R.C.S. GRASSE 403.942.642 On December 1st,...
Nicox SA Société anonyme with a registered capital of € 50,156,698 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis  R.C.S. GRASSE 403.942.642 On May 3, 2023, ...
Transfer of Nicox’s shares to Euronext Growth Paris effective on April 28, 2023
New Data on Two Nicox’s Assets, NCX 470 and NCX 1728, Presented at ARVO 2023
Nicox Provides First Quarter 2023 Financial and Business Highlights
Nicox: Ordinary Shareholder Meeting of February 28, 2023 - Approval of all Resolutions